Ostatní
Návod 
United Therapeutics Corporation
UTHR
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
20.1B
Obrat
3B
Zisk
1B
Aktiva
7B
Dluh
0B
ROE
19%
ROA
17%
PE
19
PS
8
Cena 1R
267-520
⌀ Cena
374.45
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
28-04-2026
Poslední dividenda
Profil
United Therapeutics Corporation, biotechnologická společnost, se zabývá vývojem a komercializací produktů pro řešení nenaplněných lékařských potřeb pacientů s chronickými a život ohrožujícími onemocněními ve Spojených státech a na mezinárodní úrovni. Komerční terapie zahrnuje Remodulin k léčbě pacientů s plicní arteriální hypertenzí (PAH) za účelem zmírnění příznaků spojených s tělesnou zátěží; Tyvaso, inhalační přípravek analogu prostacyklinu treprostinil ke zvýšení zátěžové schopnosti u pacientů s PAH a plicní hypertenze spojené s intersticiálním plicním onemocněním (PH-ILD); Orenitram, léková forma treprostinilu v tabletách ke zvýšení zátěžové kapacity u pacientů s PAH; Unituxin, monoklonální protilátka k léčbě vysoce rizikového neuroblastomu; a Adcirca, perorální PDE- 5 ke zvýšení zátěžové schopnosti u pacientů s PAH. Společnost se také zabývá vývojem přípravku Tyvaso DPI, suché práškové inhalační formy přípravku Tyvaso; Remunity Pump, malé, lehké, trvanlivé pumpy a samostatného kontroléru; RemoPro a Ralinepag pro léčbu PAH; Aurora-GT, přípravek genové terapie pro rekonstrukci krevních cév v plicích; a Tyvaso PERFECT a TETON studie, které jsou studiemi přípravku Tyvaso u pacientů s plicní hypertenzí skupiny 3 Světové zdravotnické organizace (WHO) spojenou s chronickou obstrukční plicní chorobou (PH-COPD). Má licenční smlouvy a smlouvy o spolupráci se společností DEKA Research & Development Corp. na vývoj polojednorázového systému pro subkutánní aplikaci treprostinilu; MannKind Corporation na vývoj a licenci treprostinilového inhalačního prášku a zařízení Dreamboat; a Arena Pharmaceuticals, Inc. na vývoj Ralinepagu. Společnost byla založena v roce 1996 a sídlí v Silver Spring v Marylandu.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
1305
Založení
1999-06-17
Podobné společnosti
$ 104.50
- $ 1.48
$ 29.05
+ $ 0.39
$ 38.90
+ $ 0.34
$ 179.48
- $ 0.02
$ 87.60
- $ 0.90
$ 196.49
- $ 8.78
$ 121.82
- $ 0.08
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 3,182.7 | 3,182.7 | 2,877.4 | 2,327.5 | 1,936.3 | 1,685.5 | 1,483.3 | 1,448.8 | 1,627.8 | 1,725.3 | 1,598.8 | 1,465.8 | 1,288.5 | 1,117.0 | 916.1 | 743.2 | 603.8 | |
| Cost of Revenues | 384.4 | 384.4 | 309.7 | 257.5 | 146.7 | 122.5 | 108.1 | 117.6 | 198.7 | 105.7 | 72.7 | 69.0 | 125.9 | 131.1 | 119.3 | 88.9 | 73.5 | |
| Gross Profit | 2,798.3 | 2,798.3 | 2,567.7 | 2,070.0 | 1,789.6 | 1,563.0 | 1,375.2 | 1,331.2 | 1,429.1 | 1,619.6 | 1,526.1 | 1,396.7 | 1,162.6 | 985.9 | 796.8 | 654.3 | 530.4 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 790.2 | 799.5 | 798.6 | 794.4 | 735.9 | 748.9 | 714.9 | 677.7 | 614.7 | 609.4 | |
| Cost of Revenues | 103.4 | 100.9 | 87.6 | 92.5 | 75.9 | 83.1 | 77.8 | 72.9 | 71.0 | 70.1 | |
| Gross Profit | 686.8 | 698.6 | 711.0 | 701.9 | 660.0 | 665.8 | 637.1 | 604.8 | 543.7 | 539.3 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 408.0 | 322.9 | 540.1 | 357.7 | 1,182.6 | 357.9 | 264.6 | 147.6 | 245.1 | 242.5 | 299.3 | 173.4 | 180.0 | 166.8 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 477.1 | 487.0 | 467.0 | 423.9 | 336.2 | 265.8 | 330.1 | 316.8 | 452.6 | 381.3 | 394.0 | 201.7 | 156.5 | 199.6 | |
| Depreciation & Amortization | 85.6 | 85.6 | 72.5 | 53.2 | 5.0 | 58.9 | 77.9 | 66.8 | 35.9 | 31.0 | 31.6 | 32.9 | 32.2 | 31.3 | 27.1 | 20.5 | 17.9 | |
| Total Operating Expenses | 1,305.8 | 1,305.8 | 1,190.7 | 885.1 | 809.9 | 1,007.1 | 781.6 | 1,518.8 | 623.7 | 594.7 | 464.4 | 697.7 | 623.8 | 693.4 | 375.1 | 336.5 | 366.4 | |
| Operating Income | 1,492.5 | 1,492.5 | 1,377.0 | 1,184.9 | 979.7 | 555.9 | 593.6 | -187.6 | 805.4 | 814.9 | 1,061.7 | 699.0 | 538.8 | 292.5 | 421.6 | 317.8 | 164.0 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 151.4 | 84.7 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 132.2 | 127.6 | ||
| Depreciation & Amortization | 77.2 | 21.9 | 21.1 | -34.6 | 19.7 | 19.1 | 18.7 | 15.0 | 13.7 | 13.3 | ||
| Total Operating Expenses | 330.1 | 310.1 | 346.5 | 319.1 | 302.3 | 322.7 | 317.2 | 248.5 | 283.6 | 212.3 | ||
| Operating Income | 356.7 | 388.5 | 364.5 | 382.8 | 357.7 | 343.1 | 319.9 | 356.3 | 260.1 | 327.0 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 192.0 | 192.0 | 199.1 | 162.7 | 45.2 | 16.7 | 28.6 | 44.2 | 28.6 | 0.0 | 0.0 | 0.0 | 0.0 | 3.8 | 3.9 | 3.5 | 2.9 | |
| Interest Expense | 19.5 | 19.5 | 42.9 | 59.3 | 32.4 | 18.6 | 23.5 | 44.2 | 13.9 | 9.0 | 3.9 | 4.7 | 17.6 | 18.1 | 16.6 | 21.4 | 19.7 | |
| Other Expense | 221.4 | 221.4 | 162.0 | 89.4 | -29.1 | 38.0 | 45.3 | 22.6 | -61.2 | -246.4 | 2.4 | 350.2 | 4.0 | 0.6 | 31.7 | -0.7 | 0.6 | |
| IBT | 1,713.9 | 1,713.9 | 1,539.0 | 1,274.3 | 950.6 | 593.9 | 638.9 | -165.0 | 758.9 | 769.5 | 1,060.2 | 1,044.4 | 525.2 | 278.9 | 440.7 | 299.1 | 147.8 | |
| Income Tax Expense | 379.2 | 379.2 | 343.9 | 289.5 | 223.3 | 118.1 | 124.1 | -60.5 | 169.7 | 351.6 | 346.5 | 392.8 | 185.1 | 104.3 | 136.2 | 81.9 | 41.9 | |
| Net Income | 1,334.7 | 1,334.7 | 1,195.1 | 984.8 | 727.3 | 475.8 | 514.8 | -104.5 | 589.2 | 417.9 | 713.7 | 651.6 | 340.1 | 174.6 | 304.4 | 217.9 | 105.9 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 43.2 | 46.4 | 51.3 | 51.1 | 49.3 | 49.8 | 46.2 | 53.8 | 51.0 | 45.3 | ||
| Interest Expense | 3.1 | 3.0 | 7.3 | 6.1 | 7.9 | 10.1 | 11.6 | 13.3 | 15.1 | 15.6 | ||
| Other Expense | 87.3 | 49.5 | 43.9 | 40.7 | 38.8 | 45.5 | 35.4 | 42.3 | 35.3 | 24.8 | ||
| IBT | 444.0 | 438.0 | 408.4 | 423.5 | 396.5 | 388.6 | 355.3 | 398.6 | 295.4 | 351.8 | ||
| Income Tax Expense | 79.7 | 99.3 | 98.9 | 101.3 | 95.2 | 79.5 | 77.2 | 92.0 | 78.3 | 84.2 | ||
| Net Income | 364.3 | 338.7 | 309.5 | 322.2 | 301.3 | 309.1 | 278.1 | 306.6 | 217.1 | 267.6 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $21.04 | $15.98 | $10.60 | $11.65 | $-2.39 | $13.54 | $9.50 | $16.29 | $14.17 | $7.06 | $3.49 | $5.84 | $3.81 | $1.89 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $19.81 | $15.00 | $10.06 | $11.54 | $-2.39 | $13.39 | $9.31 | $15.25 | $12.72 | $6.28 | $3.28 | $5.71 | $3.67 | $1.78 | |
| Shares Outstanding | 44.3 | 44.3 | 45.2 | 46.8 | 45.5 | 44.9 | 44.2 | 43.8 | 43.5 | 44.0 | 43.8 | 46.0 | 48.2 | 50.1 | 52.1 | 57.2 | 56.1 | |
| Diluted Shares Outstanding | 47.9 | 47.9 | 48.5 | 49.7 | 48.5 | 47.3 | 44.6 | 43.8 | 44.0 | 44.9 | 46.8 | 51.2 | 54.2 | 53.2 | 53.3 | 59.4 | 59.5 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.62 | $5.71 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.36 | $5.38 | ||
| Shares Outstanding | 44.3 | 43.8 | 45.1 | 44.9 | 45.2 | 44.6 | 44.4 | 47.0 | 47.0 | 46.9 | ||
| Diluted Shares Outstanding | 47.9 | 47.3 | 48.3 | 48.6 | 48.7 | 48.4 | 47.5 | 49.7 | 49.8 | 49.7 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 1,355.7 | 1,697.2 | 1,207.7 | 961.2 | 894.8 | 738.7 | 738.4 | 669.2 | 705.1 | 1,023.0 | 831.8 | 397.7 | 278.9 | 154.0 | 162.7 | 252.2 | |
| Short Term Investments | 1,615.8 | 1,569.8 | 1,786.4 | 1,877.5 | 1,035.9 | 1,096.3 | 747.5 | 746.7 | 222.3 | 27.8 | 122.0 | 297.8 | 409.6 | 325.2 | 240.8 | 374.9 | |
| Total Cash & ST Investments | 2,971.5 | 3,267.0 | 2,994.1 | 4,154.9 | 3,580.6 | 2,984.6 | 2,253.4 | 1,858.5 | 1,430.1 | 1,050.8 | 953.8 | 695.5 | 688.5 | 479.2 | 403.5 | 627.1 | |
| Accounts Receivable | 290.7 | 279.3 | 278.9 | 220.4 | 198.7 | 157.4 | 151.4 | 175.7 | 297.1 | 214.5 | 192.8 | 162.3 | 126.3 | 116.6 | 88.7 | 73.7 | |
| Inventory | 136.5 | 157.9 | 111.8 | 102.0 | 93.8 | 86.5 | 93.4 | 101.0 | 107.9 | 100.0 | 81.3 | 66.9 | 47.8 | 37.3 | 46.0 | 35.5 | |
| Other Current Assets | 220.8 | 169.7 | 166.2 | 219.2 | 100.4 | 88.3 | 133.8 | 75.4 | 115.5 | 59.5 | 47.4 | 49.4 | 46.4 | 3.8 | 6.2 | 759.9 | |
| Total Current Assets | 3,619.5 | 3,873.9 | 3,551.0 | 3,380.3 | 2,323.6 | 2,167.2 | 1,864.5 | 1,768.0 | 1,447.9 | 1,424.8 | 1,275.3 | 974.2 | 909.0 | 668.5 | 562.5 | 765.1 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 1,136.6 | 1,593.1 | 1,899.9 | 1,697.2 | 1,553.9 | 1,355.7 | 1,251.5 | 1,207.7 | 1,107.7 | 1,067.3 | |
| Short Term Investments | 1,631.0 | 1,455.6 | 1,421.4 | 1,569.8 | 1,772.6 | 1,615.8 | 1,456.3 | 1,786.4 | 3,828.6 | 3,635.3 | |
| Total Cash & ST Investments | 2,767.6 | 3,048.7 | 3,321.3 | 3,267.0 | 3,326.5 | 2,971.5 | 2,707.8 | 2,994.1 | 4,936.3 | 4,702.6 | |
| Accounts Receivable | 297.7 | 379.3 | 322.0 | 279.3 | 341.8 | 290.7 | 307.3 | 278.9 | 258.6 | 272.7 | |
| Inventory | 176.5 | 169.2 | 165.4 | 157.9 | 146.7 | 136.5 | 120.2 | 111.8 | 104.3 | 103.3 | |
| Other Current Assets | 252.2 | 229.7 | 131.1 | 169.7 | 185.4 | 220.8 | 113.4 | 166.2 | 220.5 | 158.4 | |
| Total Current Assets | 3,494.0 | 3,826.9 | 3,939.8 | 3,873.9 | 4,000.4 | 3,619.5 | 3,248.7 | 3,551.0 | 3,458.9 | 3,213.4 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 1,094.6 | 1,222.4 | 1,045.4 | 861.5 | 780.9 | 731.6 | 738.5 | 699.7 | 545.7 | 489.3 | 495.8 | 478.4 | 465.0 | 453.7 | 366.0 | 306.0 | |
| Goodwill | 0.0 | 32.3 | 33.7 | 28.0 | 28.0 | 28.0 | 28.0 | 31.5 | 13.7 | 10.3 | 10.3 | 10.3 | 10.7 | 10.5 | 8.1 | 2.5 | |
| Intangible Assets | 115.2 | 79.6 | 80.5 | 16.5 | 16.6 | 130.1 | 130.3 | 139.3 | 31.9 | 23.5 | 18.1 | 19.2 | 3.4 | 5.9 | 14.0 | 7.4 | |
| Long-Term Investments | 1,359.4 | 1,475.3 | 1,909.8 | 1,316.2 | 1,649.9 | 1,149.6 | 767.5 | 442.6 | 502.7 | 2.3 | 38.0 | 122.8 | 453.5 | 311.1 | 349.0 | 138.0 | |
| Other Long-Term Assets | 138.9 | 222.1 | 151.8 | 114.3 | 108.2 | 169.9 | 154.6 | 224.2 | 224.1 | 197.1 | 154.3 | 97.8 | 53.3 | 26.8 | 27.7 | 10.6 | |
| Total Long-Term Assets | 3,103.7 | 3,490.1 | 3,616.0 | 2,664.2 | 2,845.5 | 2,447.8 | 2,048.9 | 1,633.0 | 1,431.5 | 900.8 | 909.1 | 910.2 | 1,178.6 | 958.1 | 955.6 | 666.6 | |
| Total Assets | 6,723.2 | 7,364.0 | 7,167.0 | 6,044.5 | 5,169.1 | 4,615.0 | 3,913.4 | 3,401.0 | 2,879.4 | 2,325.6 | 2,184.4 | 1,884.4 | 2,087.6 | 1,626.6 | 1,518.1 | 1,431.6 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 1,555.6 | 1,362.4 | 1,302.7 | 1,222.4 | 1,156.7 | 1,094.6 | 1,074.0 | 1,045.4 | 992.2 | 938.9 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 32.3 | 0.0 | 0.0 | 0.0 | 33.7 | 0.0 | 0.0 | |
| Intangible Assets | 116.7 | 111.5 | 111.7 | 79.6 | 112.1 | 115.2 | 115.4 | 80.5 | 44.4 | 44.5 | |
| Long-Term Investments | 1,656.3 | 1,917.7 | 1,710.7 | 1,475.3 | 1,279.4 | 1,330.4 | 1,491.9 | 1,909.8 | 2,060.8 | 2,023.6 | |
| Other Long-Term Assets | 173.6 | 233.3 | 222.4 | 222.1 | 183.6 | 167.9 | 169.1 | 151.8 | 141.7 | 135.3 | |
| Total Long-Term Assets | 3,857.1 | 4,081.1 | 3,804.1 | 3,490.1 | 3,122.7 | 3,103.7 | 3,246.5 | 3,616.0 | 3,564.7 | 3,467.9 | |
| Total Assets | 7,351.1 | 7,908.0 | 7,743.9 | 7,364.0 | 7,123.1 | 6,723.2 | 6,495.2 | 7,167.0 | 7,023.6 | 6,681.3 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 325.3 | 6.0 | 5.6 | 4.1 | 3.8 | 4.1 | 9.9 | 23.1 | 8.4 | 8.1 | 7.5 | 7.0 | 6.7 | 10.2 | 47.3 | 16.1 | |
| Short-Term Debt | 400.0 | 300.0 | 400.0 | 0.0 | 0.0 | 0.0 | 250.0 | 0.0 | 0.0 | 0.0 | 5.4 | 126.5 | 282.5 | 0.0 | 0.0 | 236.0 | |
| Other Current Liabilities | 107.0 | 432.1 | 398.8 | 339.1 | 301.6 | 319.2 | 39.6 | 253.5 | 436.3 | 324.4 | 57.5 | 10.3 | 25.0 | 166.6 | 165.3 | 126.3 | |
| Current Liabilities | 832.3 | 738.1 | 804.4 | 343.2 | 305.4 | 323.3 | 463.0 | 276.6 | 444.7 | 332.5 | 440.8 | 504.3 | 687.7 | 176.8 | 212.6 | 428.7 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 468.0 | 432.0 | 367.0 | 6.0 | 363.9 | 325.3 | 305.1 | 5.6 | 333.4 | 292.0 | |
| Short-Term Debt | 0.0 | 0.0 | 200.0 | 300.0 | 400.0 | 400.0 | 400.0 | 400.0 | 300.0 | 0.0 | |
| Other Current Liabilities | 78.3 | 95.1 | 154.5 | 432.1 | 109.5 | 107.0 | 460.6 | 398.8 | 110.7 | 78.3 | |
| Current Liabilities | 546.3 | 527.1 | 721.5 | 738.1 | 873.4 | 832.3 | 860.6 | 804.4 | 744.1 | 370.3 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 100.0 | 0.0 | 300.0 | 800.0 | 800.0 | 800.0 | 600.0 | 250.0 | 250.0 | 0.0 | 0.0 | 0.0 | 3.7 | 275.0 | 194.2 | 68.9 | |
| Capital Leases | 0.0 | 38.6 | 32.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 1,026.0 | 920.0 | 1,182.2 | 1,247.8 | 1,210.2 | 1,219.8 | 1,133.0 | 612.4 | 777.6 | 463.4 | 584.8 | 618.8 | 783.3 | 531.7 | 569.6 | 547.7 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 200.0 | 300.0 | 500.0 | 800.0 | |
| Capital Leases | 0.0 | 0.0 | 0.0 | 38.6 | 0.0 | 0.0 | 0.0 | 32.8 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 42.4 | 0.0 | 0.0 | |
| Total Liabilities | 760.9 | 734.4 | 936.7 | 920.0 | 1,022.2 | 1,026.0 | 1,157.1 | 1,182.2 | 1,311.5 | 1,270.3 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.7 | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | |
| Retained Earnings | 6,611.8 | 7,222.2 | 6,027.1 | 5,042.3 | 4,315.0 | 3,839.2 | 3,325.2 | 3,434.8 | 2,845.6 | 2,433.5 | 1,719.8 | 1,068.1 | 728.0 | 553.5 | 249.0 | 31.2 | |
| Comprehensive Income | -14.9 | -3.4 | -12.8 | -55.5 | -23.0 | -14.2 | -14.2 | -7.9 | -19.6 | -16.8 | -20.4 | -16.7 | -13.2 | -15.0 | -10.9 | -9.2 | |
| Total Common Equity | 5,697.2 | 6,444.0 | 5,984.8 | 4,796.7 | 3,958.9 | 3,395.2 | 2,780.4 | 2,788.6 | 2,101.8 | 1,862.2 | 1,599.6 | 1,265.6 | 1,304.3 | 1,094.9 | 948.5 | 883.9 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | |
| Retained Earnings | 8,192.6 | 7,853.9 | 7,544.4 | 7,222.2 | 6,920.9 | 6,611.8 | 6,333.7 | 6,027.1 | 5,810.0 | 5,542.4 | |
| Comprehensive Income | 0.1 | 0.0 | -1.2 | -3.4 | 7.4 | -14.9 | -15.6 | -12.8 | -43.7 | -50.6 | |
| Total Common Equity | 6,590.2 | 7,173.6 | 6,807.2 | 6,444.0 | 6,100.9 | 5,697.2 | 5,338.1 | 5,984.8 | 5,712.1 | 5,411.0 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 500.0 | 300.0 | 700.0 | 800.0 | 800.0 | 800.0 | 850.0 | 250.0 | 250.0 | 0.0 | 5.4 | 126.5 | 286.2 | 275.0 | 194.2 | 304.9 | |
| Book Value | 5,697.2 | 6,444.0 | 5,984.8 | 4,796.7 | 3,958.9 | 3,395.2 | 2,780.4 | 2,788.6 | 2,101.8 | 1,862.2 | 1,599.6 | 1,265.6 | 1,304.3 | 1,094.9 | 948.5 | 883.9 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 6,590.2 | 7,173.6 | 6,807.2 | 6,444.0 | 6,100.9 | 5,697.2 | 5,338.1 | 5,984.8 | 5,712.1 | 5,411.0 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1,069.4 | 1,334.7 | 1,195.1 | 984.8 | 727.3 | 475.8 | 514.8 | -104.5 | 589.2 | 417.9 | 713.7 | 651.6 | 340.1 | 174.6 | 304.4 | 217.9 | 105.9 | |
| Depreciation & Amortization | 60.7 | 85.6 | 72.5 | 53.2 | 51.3 | 49.9 | 49.9 | 45.9 | 35.9 | 31.0 | 31.6 | 32.9 | 32.2 | 31.3 | 27.1 | 20.5 | 17.9 | |
| Stock-Based Compensation | 113.0 | 147.7 | 144.0 | 39.1 | 106.8 | 138.5 | 163.8 | 45.4 | -26.4 | 73.5 | 12.1 | 280.3 | 190.1 | 320.8 | 30.1 | -15.7 | 113.9 | |
| Change Working Capital | -149.8 | -106.4 | -60.2 | -97.8 | -141.2 | -174.2 | 59.7 | -180.9 | 124.4 | -78.4 | -117.4 | -202.2 | -385.6 | -216.7 | -208.2 | -111.3 | -74.8 | |
| Change In Accounts Receivable | -18.1 | -70.9 | -0.4 | -58.5 | -21.7 | -41.3 | -6.0 | 24.4 | 121.4 | -82.7 | -21.7 | -30.5 | -35.7 | -10.0 | -24.0 | -16.2 | -23.5 | |
| Change In Accounts Payable | 8.9 | 97.9 | 0.0 | 57.1 | 44.5 | -12.5 | 38.6 | -16.3 | -11.0 | 66.2 | 0.6 | 17.0 | -6.8 | 7.5 | -37.2 | 16.7 | -2.7 | |
| Change In Inventories | -34.1 | -52.6 | -46.9 | -13.6 | -13.4 | -7.5 | 10.3 | 12.9 | 9.3 | -0.5 | -24.5 | -6.8 | -21.0 | -12.4 | -5.9 | -16.1 | -9.2 | |
| Other Non-cash Items | 74.3 | 2.0 | -24.3 | -1.3 | 58.3 | 65.9 | -47.0 | -29.7 | 1.8 | -19.4 | 9.5 | 5.4 | -6.7 | 11.0 | 33.9 | 336.3 | 6.6 | |
| Cash from Operations | 1,105.6 | 0.0 | 0.0 | 978.0 | 802.5 | 598.2 | 755.7 | -206.6 | 778.4 | 474.2 | 643.6 | 382.8 | 355.3 | 425.3 | 323.6 | 250.2 | 211.5 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 364.3 | 338.7 | 309.5 | 322.2 | 301.3 | 309.1 | 278.1 | 306.6 | 217.1 | 267.6 | |
| Depreciation & Amortization | 22.8 | 21.9 | 21.1 | 19.8 | 19.7 | 19.1 | 18.7 | 15.0 | 13.7 | 13.3 | |
| Stock-Based Compensation | 39.0 | 39.1 | 37.8 | 31.8 | 27.0 | 41.7 | 49.7 | 25.6 | 16.6 | 21.1 | |
| Change Working Capital | -143.9 | 162.5 | -203.0 | 78.0 | -4.2 | 13.0 | -108.8 | 39.8 | -91.7 | 10.9 | |
| Change In Accounts Receivable | -52.5 | 81.6 | -57.3 | -42.7 | 62.5 | -51.1 | 16.5 | -28.3 | -20.3 | 14.0 | |
| Change In Accounts Payable | 66.7 | 31.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -23.1 | 4.3 | |
| Change In Inventories | -16.5 | -17.5 | -7.4 | -11.2 | -11.6 | -11.3 | -14.7 | -9.3 | -7.0 | -3.1 | |
| Other Non-cash Items | -33.6 | -0.1 | 26.3 | 9.4 | -2.6 | -5.7 | -5.5 | -10.5 | -5.0 | 35.8 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 150.7 | 346.2 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -227.7 | -520.5 | -246.5 | -230.4 | -138.8 | -120.8 | -59.3 | -83.7 | -184.4 | -86.3 | -43.2 | -49.8 | -47.4 | -31.9 | -111.9 | -36.0 | -18.6 | |
| Acquisitions | 147.9 | 0.0 | -30.5 | -89.2 | 7.1 | -47.6 | 0.0 | -20.5 | -129.1 | 0.1 | -2.1 | 0.0 | -549.6 | -30.8 | -527.9 | -3.5 | 0.0 | |
| Investments | -1,713.1 | -3,460.4 | -1,646.1 | -2,514.3 | -1,708.6 | -1,895.3 | -2,308.8 | -1,271.5 | -862.0 | -830.6 | -36.8 | -117.0 | -163.7 | -762.2 | -579.3 | -815.7 | -662.2 | |
| Sales of Investment | 2,438.0 | 1,583.9 | 2,368.8 | 2,137.3 | 1,025.3 | 1,529.2 | 1,627.2 | 1,040.3 | 400.9 | 72.9 | 130.4 | 320.4 | 549.6 | 529.9 | 527.9 | 733.9 | 457.7 | |
| Other Investing Activities | -261.1 | 0.0 | 0.0 | -23.0 | 3.5 | 47.6 | 2.4 | 0.0 | -46.0 | 8.3 | 0.0 | 350.0 | 549.6 | 0.0 | 527.9 | 0.0 | 13.9 | |
| Cash from Investing | 384.0 | 0.0 | 0.0 | -719.6 | -811.5 | -486.9 | -738.5 | -335.4 | -820.6 | -835.6 | 48.3 | 503.6 | 338.5 | -295.0 | -163.4 | -121.3 | -209.2 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -172.9 | -210.5 | -62.2 | -74.9 | -86.7 | -76.5 | -45.1 | -38.2 | -78.7 | -65.7 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | -30.0 | 0.0 | 0.0 | 0.0 | -89.2 | 237.1 | |
| Investments | -545.3 | -415.9 | -1,806.9 | -692.3 | -478.5 | -407.8 | -230.5 | -529.3 | -308.0 | -644.8 | |
| Sales of Investment | -780.1 | 182.5 | 1,569.8 | 611.7 | 478.0 | 387.2 | 196.5 | 1,307.1 | 526.7 | 407.7 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -8.7 | -247.7 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 42.1 | -313.4 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -300.0 | 0.0 | 0.0 | -100.0 | -800.0 | 0.0 | -50.0 | -200.0 | -250.0 | 0.0 | -8.8 | -133.2 | -317.8 | -1.3 | -1.0 | -251.0 | -31.4 | |
| Debt Issued | 0.0 | 300.0 | -400.0 | 0.0 | 1,600.0 | 800.0 | 0.0 | 800.0 | 500.0 | 250.0 | 3.4 | 12.1 | 158.1 | 12.5 | 81.8 | 140.3 | 336.3 | |
| Issuance of Common Stock | 71.1 | 0.0 | 0.0 | 0.0 | 88.4 | 5.6 | 4.7 | 4.1 | 3.9 | 4.1 | 4.3 | 4.0 | 3.3 | 2.7 | 0.0 | 27.3 | 0.0 | |
| Repurchase of Common Stock | -1,011.8 | -1,000.0 | -1,012.2 | -13.8 | -11.4 | -10.8 | -3.7 | -2.1 | 0.0 | -250.0 | -500.0 | -394.5 | -483.1 | -42.4 | -188.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.7 | -4.1 | 0.0 | 0.0 | -7.7 | -39.3 | -190.2 | -26.6 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -7.1 | 0.0 | 0.0 | 101.9 | 798.4 | 50.0 | 36.8 | 813.3 | 252.4 | 289.2 | 14.5 | 116.0 | 411.2 | 62.5 | 19.9 | 5.7 | 178.2 | |
| Cash from Financing | -1,201.2 | 0.0 | 0.0 | -11.9 | 75.4 | 44.8 | -16.9 | 611.2 | 6.3 | 43.3 | -497.7 | -446.9 | -576.5 | -5.1 | -169.1 | -218.1 | 146.8 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -100.0 | 0.0 | |
| Debt Issued | 0.0 | 0.0 | -200.0 | -100.0 | -100.0 | -100.0 | -100.0 | -100.0 | 300.0 | -300.0 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | -1,000.0 | 0.0 | 0.0 | -0.3 | -0.4 | -11.5 | -1,000.0 | -0.1 | -0.2 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 7.3 | 7.8 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -92.8 | 7.6 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 288.4 | -140.1 | 489.5 | 246.5 | 66.4 | 156.1 | 0.3 | 69.2 | -35.9 | -317.9 | 191.2 | 434.1 | 113.4 | 124.9 | -8.6 | -89.5 | 151.8 | |
| Closing Cash Balance | 1,355.7 | 1,557.1 | 1,697.2 | 1,207.7 | 961.2 | 894.8 | 738.7 | 738.4 | 669.2 | 705.1 | 1,023.0 | 831.8 | 397.7 | 278.9 | 154.0 | 162.7 | 252.2 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 217.0 | -253.0 | -306.8 | 202.7 | 143.3 | 198.2 | 104.2 | 43.8 | 100.0 | 40.4 | |
| Closing Cash Balance | 1,557.1 | 1,340.1 | 1,593.1 | 1,899.9 | 1,697.2 | 1,553.9 | 1,355.7 | 1,251.5 | 1,207.7 | 1,107.7 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 877.9 | 1,040.7 | 1,080.6 | 747.6 | 663.7 | 477.4 | 696.4 | -290.3 | 594.0 | 387.9 | 600.4 | 333.0 | 307.8 | 393.4 | 211.7 | 214.2 | 192.9 | |
| Real Free Cash Flow | 764.9 | 893.0 | 936.6 | 708.5 | 556.9 | 338.9 | 532.6 | -335.7 | 620.4 | 314.4 | 588.3 | 52.7 | 117.8 | 72.6 | 181.6 | 229.9 | 79.0 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 173.3 | 351.6 | 129.5 | 386.3 | 254.5 | 300.7 | 187.1 | 338.3 | 72.0 | 280.5 | |
| Real Free Cash Flow | 134.3 | 312.5 | 91.7 | 354.5 | 227.5 | 259.0 | 137.4 | 312.7 | 55.4 | 259.4 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 18.8 | 16.6 | -1.4 |
| P/S | 7.9 | 5.1 | 9.4 |
| P/B | 3.8 | 3.1 | 5.2 |
| P/FCF | 28.1 | -9.9 | -1.5 |
| Market cap | $20.1 | $12.4 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 12.2 % | 0 % |
| Debt to Income | 0 % | 58.5 % | 0 % |
| Debt to Free cash flow | 0 % | 1218.9 % | 0 % |
| Interest expense percentage | 1.3 % | 2.5 % | 0 % |
| Current ratio | 6.4 | 4.4 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 20.3 % | 18.9 % | 0 % |
| ROA | 18.2 % | 14 % | 0 % |
| CapEx to Revenue | 13.9 % | 6.2 % | 0 % |
| RaD to Revenue | 0 % | 23.9 % | 0 % |
| ROEM | 2,438,850.6 | 1492927.5 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 88.6 % | 90.7 % | 0 % |
| Operating margin | 47.7 % | 40.5 % | 0 % |
| Net margin | 40.7 % | 30 % | 0 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0.2 % | 0 % |
| Dividend payout percentage | 0 % | 1.2 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 47.3 mil | 49.7 mil |
| Employee count | 1.3 tis | 0.6 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
